OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA PATIENTS WITH ACTIVE REFRACTORY DISEASE BEFORE TRANSPLANT

Introduction: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is the most potent post-remission treatment for Acute Myeloid Leukemia (AML) to reduce relapse rates. However, achieving Complete Remission (CR) and Minimal Residual Disease (MRD) before transplant are crucial predictors of rela...

Descripció completa

Dades bibliogràfiques

Autors principals:	FS Azevedo, VC Molla, PHA Moraes, EL Rosa, RS Szor, CC Justino, CD Liz, AM Fonseca, C Arrais
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-10-01
Col·lecció:	Hematology, Transfusion and Cell Therapy
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2531137924020716
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!